197 related articles for article (PubMed ID: 35197508)
1. Diagnosing pleural effusions using mass spectrometry-based multiplexed targeted proteomics quantitating mid- to high-abundance markers of cancer, infection/inflammation and tuberculosis.
Robak A; Kistowski M; Wojtas G; Perzanowska A; Targowski T; Michalak A; Krasowski G; Dadlez M; Domański D
Sci Rep; 2022 Feb; 12(1):3054. PubMed ID: 35197508
[TBL] [Abstract][Full Text] [Related]
2. A Multiplexed Cytokeratin Analysis Using Targeted Mass Spectrometry Reveals Specific Profiles in Cancer-Related Pleural Effusions.
Domanski D; Perzanowska A; Kistowski M; Wojtas G; Michalak A; Krasowski G; Dadlez M
Neoplasia; 2016 Jul; 18(7):399-412. PubMed ID: 27435923
[TBL] [Abstract][Full Text] [Related]
3. In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.
Liu PJ; Chen CD; Wang CL; Wu YC; Hsu CW; Lee CW; Huang LH; Yu JS; Chang YS; Wu CC; Yu CJ
Mol Cell Proteomics; 2015 Apr; 14(4):917-32. PubMed ID: 25638566
[TBL] [Abstract][Full Text] [Related]
4. Targeted proteomics pipeline reveals potential biomarkers for the diagnosis of metastatic lung cancer in pleural effusion.
Chen CD; Wang CL; Yu CJ; Chien KY; Chen YT; Chen MC; Chang YS; Wu CC; Yu JS
J Proteome Res; 2014 Jun; 13(6):2818-29. PubMed ID: 24787432
[TBL] [Abstract][Full Text] [Related]
5. An MRM-Based Cytokeratin Marker Assay as a Tool for Cancer Studies: Application to Lung Cancer Pleural Effusions.
Perzanowska A; Fatalska A; Wojtas G; Lewandowicz A; Michalak A; Krasowski G; Borchers CH; Dadlez M; Domanski D
Proteomics Clin Appl; 2018 Mar; 12(2):. PubMed ID: 29352525
[TBL] [Abstract][Full Text] [Related]
6. Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.
Lee CY; Hong JY; Lee MG; Suh IB
Yonsei Med J; 2017 Nov; 58(6):1144-1151. PubMed ID: 29047238
[TBL] [Abstract][Full Text] [Related]
7. Proteome screening of pleural effusions identifies IL1A as a diagnostic biomarker for non-small cell lung cancer.
Li Y; Lian H; Jia Q; Wan Y
Biochem Biophys Res Commun; 2015 Feb; 457(2):177-82. PubMed ID: 25554695
[TBL] [Abstract][Full Text] [Related]
8. Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.
Mundt F; Johansson HJ; Forshed J; Arslan S; Metintas M; Dobra K; Lehtiö J; Hjerpe A
Mol Cell Proteomics; 2014 Mar; 13(3):701-15. PubMed ID: 24361865
[TBL] [Abstract][Full Text] [Related]
9. Metabonomics by proton nuclear magnetic resonance in human pleural effusions: A route to discriminate between benign and malignant pleural effusions and to target small molecules as potential cancer biomarkers.
Zennaro L; Vanzani P; Nicolè L; Cappellesso R; Fassina A
Cancer Cytopathol; 2017 May; 125(5):341-348. PubMed ID: 28140518
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin, C-reactive protein, and cell counts in the diagnosis of parapneumonic pleural effusions.
San José ME; Valdés L; Vizcaíno LH; Mora T; Pose A; Soneira E; Crecente C; González-Barcala FJ
J Investig Med; 2010 Dec; 58(8):971-6. PubMed ID: 20930646
[TBL] [Abstract][Full Text] [Related]
11. Expression of YKL-40 and MIP-1a proteins in exudates and transudates: biomarkers for differential diagnosis of pleural effusions? A pilot study.
Adamidi T; Soulitzis N; Neofytou E; Zannetos S; Georgiou A; Benidis K; Papadopoulos A; Siafakas NM; Schiza SE
BMC Pulm Med; 2015 Dec; 15():150. PubMed ID: 26620310
[TBL] [Abstract][Full Text] [Related]
12. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
13. Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions.
Yang WB; Liang QL; Ye ZJ; Niu CM; Ma WL; Xiong XZ; Du RH; Zhou Q; Zhang JC; Shi HZ
PLoS One; 2012; 7(7):e40450. PubMed ID: 22792330
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
Moschos C; Porfiridis I; Psallidas I; Kollintza A; Stathopoulos GT; Papiris SA; Roussos C; Kalomenidis I
Respirology; 2009 Jul; 14(5):716-22. PubMed ID: 19476604
[TBL] [Abstract][Full Text] [Related]
15. Integrated semi-targeted metabolomics analysis reveals distinct metabolic dysregulation in pleural effusion caused by tuberculosis and malignancy.
Che N; Ma Y; Ruan H; Xu L; Wang X; Yang X; Liu X
Clin Chim Acta; 2018 Feb; 477():81-88. PubMed ID: 29208371
[TBL] [Abstract][Full Text] [Related]
16. Discrimination of tuberculous from carcinomatous pleural effusion by biochemical markers: adenosine deaminase, lysozyme, fibronectin and carcinoembryonic antigen.
Moriwaki Y; Kohjiro N; Itoh M; Nakatsuji Y; Okada M; Ishihara H; Tachibana I; Kokubu T
Jpn J Med; 1989; 28(4):478-84. PubMed ID: 2810921
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
[TBL] [Abstract][Full Text] [Related]
18. Pleural effusion, tuberculosis and HIV-1 infection in Kigali, Rwanda.
Batungwanayo J; Taelman H; Allen S; Bogaerts J; Kagame A; Van de Perre P
AIDS; 1993 Jan; 7(1):73-9. PubMed ID: 8442920
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic significance of interferon-gamma in tuberculous pleural effusions.
Aoe K; Hiraki A; Murakami T; Eda R; Maeda T; Sugi K; Takeyama H
Chest; 2003 Mar; 123(3):740-4. PubMed ID: 12628872
[TBL] [Abstract][Full Text] [Related]
20. Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?
Ogata Y; Aoe K; Hiraki A; Murakami K; Kishino D; Chikamori K; Maeda T; Ueoka H; Kiura K; Tanimoto M
Acta Med Okayama; 2011 Aug; 65(4):259-63. PubMed ID: 21860532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
